During the forecast period, the global bloodstream infection testing market is expected to increase at a CAGR of 7.0 percent, from $6.8 billion in 2018 to $XX.X billion in 2028. (2021-2028). The market is largely driven by factors such as the rising frequency of bacterial infections and greater awareness among end-users such as healthcare providers and patients about the importance of precise diagnosis and treatment of bloodstream infections.
Blood Stream Infection Testing Market is the process of determining whether or not bacteria that can cause infections are present in the blood. The presence and/or growth rate of bacteria are determined using a variety of ways to assess if they may cause infection, select which antibiotic should be used for treatment, and track treatment response.
Read More @ https://cmiinfopiece.blogspot.com/2022/01/the-global-blood-stream-infection.html
